Tianqi Xu

717 total citations
44 papers, 478 citations indexed

About

Tianqi Xu is a scholar working on Molecular Biology, Epidemiology and Molecular Medicine. According to data from OpenAlex, Tianqi Xu has authored 44 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 7 papers in Epidemiology and 7 papers in Molecular Medicine. Recurrent topics in Tianqi Xu's work include Antibiotic Resistance in Bacteria (7 papers), Glioma Diagnosis and Treatment (4 papers) and Gut microbiota and health (4 papers). Tianqi Xu is often cited by papers focused on Antibiotic Resistance in Bacteria (7 papers), Glioma Diagnosis and Treatment (4 papers) and Gut microbiota and health (4 papers). Tianqi Xu collaborates with scholars based in China, Maldives and India. Tianqi Xu's co-authors include Yuan Liu, Jia Feng, Zhiqiang Wang, Tao� Lv, Xiaohua Zhang, Yifeng Miao, Dan Fang, Liemei Guo, Weizhen Gao and Chenxi Zheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Tianqi Xu

43 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianqi Xu China 12 269 145 59 53 49 44 478
Shijie Zhang China 16 362 1.3× 235 1.6× 31 0.5× 66 1.2× 37 0.8× 39 594
Wenxia Yao China 14 246 0.9× 116 0.8× 45 0.8× 56 1.1× 82 1.7× 27 496
Giovanna C. Cavalcante Brazil 14 329 1.2× 107 0.7× 35 0.6× 40 0.8× 53 1.1× 37 539
Anthony V. Nguyen United States 11 358 1.3× 59 0.4× 21 0.4× 34 0.6× 55 1.1× 35 635
Yushi Chen China 11 311 1.2× 137 0.9× 57 1.0× 21 0.4× 58 1.2× 33 485
Lixin Yan China 10 197 0.7× 134 0.9× 23 0.4× 96 1.8× 26 0.5× 16 364
Zijing Xia China 16 424 1.6× 242 1.7× 36 0.6× 69 1.3× 76 1.6× 30 754
Nina Grossmann Germany 8 340 1.3× 69 0.5× 52 0.9× 48 0.9× 58 1.2× 9 622
Dezhi Li China 13 259 1.0× 102 0.7× 22 0.4× 62 1.2× 39 0.8× 25 425
Shujun Yang China 13 540 2.0× 141 1.0× 59 1.0× 20 0.4× 48 1.0× 31 735

Countries citing papers authored by Tianqi Xu

Since Specialization
Citations

This map shows the geographic impact of Tianqi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianqi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianqi Xu more than expected).

Fields of papers citing papers by Tianqi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianqi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianqi Xu. The network helps show where Tianqi Xu may publish in the future.

Co-authorship network of co-authors of Tianqi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Tianqi Xu. A scholar is included among the top collaborators of Tianqi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianqi Xu. Tianqi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Tianqi, et al.. (2025). Restoring tigecycline efficacy with lysine supplementation in tmexCD-toprJ-positive bacteria. PubMed. 66(2). 107511–107511.
2.
Fang, Dan, Tianqi Xu, Yue Sun, et al.. (2025). Methionine-driven methylation modification overcomes plasmid-mediated high-level tigecycline resistance. Nature Communications. 16(1). 417–417. 8 indexed citations
3.
Xu, Tianqi, et al.. (2025). Vitamin B6 resensitizes mcr-carrying Gram-negative bacteria to colistin. Communications Biology. 8(1). 459–459. 3 indexed citations
4.
Xu, Tianqi, Fan Li, Yichao Jin, et al.. (2025). Framework Nucleic Acid‐Mediated DNAzyme Chaperoning for Sensitive Trace Metal Ion Mapping on Live Neuronal Cell Membranes. Angewandte Chemie International Edition. 64(35). e202506640–e202506640. 1 indexed citations
5.
Wang, Huanhuan, Jia Chai, Tianqi Xu, et al.. (2024). STC1 promotes esophageal squamous cell carcinoma progression and is associated with poor prognosis. Pathology - Research and Practice. 265. 155744–155744. 1 indexed citations
6.
Liu, Xiyu, Zijian Shi, Yuan Cao, et al.. (2024). The role of PDCD6 in stemness maintenance of Glioblastoma. Pathology - Research and Practice. 264. 155727–155727. 1 indexed citations
7.
Fang, Dan, Tianqi Xu, Jingyi Sun, et al.. (2023). Nicotinamide Mononucleotide Ameliorates Sleep Deprivation‐Induced Gut Microbiota Dysbiosis and Restores Colonization Resistance against Intestinal Infections. Advanced Science. 10(9). e2207170–e2207170. 34 indexed citations
8.
Xu, Tianqi, et al.. (2023). A Dietary Source of High Level of Fluoroquinolone Tolerance in mcr -Carrying Gram-Negative Bacteria. Research. 6. 245–245. 12 indexed citations
9.
Liu, Jian, Yixi Xu, Tianqi Xu, et al.. (2023). MUC1 promotes cancer stemness and predicts poor prognosis in osteosarcoma. Pathology - Research and Practice. 242. 154329–154329. 6 indexed citations
10.
Jiang, Dongbo, Yong Zhang, Tianqi Xu, et al.. (2022). Elevated ubiquitination contributes to protective immunity against severe SARS‐CoV‐2 infection. Clinical and Translational Medicine. 12(12). e1103–e1103. 10 indexed citations
11.
Xu, Tianqi, Jin Liu, Jia Chai, et al.. (2022). ZIC5 promotes aggressiveness and cancer stemness in cervical squamous cell carcinoma. Pathology - Research and Practice. 241. 154268–154268. 6 indexed citations
12.
Xu, Tianqi, Feng Jia, Min Li, et al.. (2022). Engineering nucleic acid functional probes in neuroimaging. TrAC Trends in Analytical Chemistry. 154. 116651–116651. 3 indexed citations
13.
Wang, Kaijing, Jie Wei, Jing Ma, et al.. (2022). Phosphorylation of PBK/TOPK Tyr74 by JAK2 promotes Burkitt lymphoma tumor growth. Cancer Letters. 544. 215812–215812. 5 indexed citations
14.
Zhao, Yun, Guorui Sun, Jia Chai, et al.. (2022). FBXO39 predicts poor prognosis and correlates with tumor progression in cervical squamous cell carcinoma. Pathology - Research and Practice. 238. 154090–154090. 3 indexed citations
15.
Ma, Jing, Kaijing Wang, Jia Chai, et al.. (2021). High RSK4 expression constitutes a predictor of poor prognosis for patients with clear cell renal carcinoma. Pathology - Research and Practice. 227. 153642–153642. 5 indexed citations
16.
Wang, Kaijing, Jia Chai, Jie Wei, et al.. (2021). TOPK: A new predictor of the therapeutic response to neoadjuvant chemotherapy and prognosis in triple-negative breast cancer. Pathology - Research and Practice. 226. 153603–153603. 3 indexed citations
18.
Xu, Tianqi, Li Xu, Panpan Wang, et al.. (2020). Primary lymphoma of bone: a population-based study of 2558 patients. Therapeutic Advances in Hematology. 11. 154250314–154250314. 11 indexed citations
19.
Chen, Ligang, et al.. (2020). RSK4: a new prognostic factor in glioma. Pathology - Research and Practice. 216(8). 153020–153020. 8 indexed citations
20.
Gao, Weizhen, et al.. (2018). Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients. Journal of Translational Medicine. 16(1). 368–368. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026